NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aillis, Inc.

Aillis, Inc.

Private
TokyoHealthcare & Life Scienceshttps://aillis.jp/

Last Round

Series D

Mar 27, 2024

Total Funding Raised

$81.17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Aillis, Inc. is a Japanese medical technology company that develops and manufactures AI-powered medical devices, including its flagship influenza diagnostic system, nodoca.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Computer Vision

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

medical AIdiagnostic supportcomputer visionmedical devicepoint-of-care testingAI diagnosticsinfectious disease screeningclinical workflowmedtechAI healthcaredigital healthusage-based SaaShealthtechAI-assisted diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aillis, Inc. Comparables

Compare Aillis, Inc. with similar companies based on industry and business-model similarity.

Aillis, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AI Medical Service Inc.
69%
Fujifilm Holdings Corporation
67%
LPIXEL Inc.
66%

Aillis, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 27, 2024
Series CJun 29, 2022
Series BAug 5, 2020
Series BMay 7, 2019

Key People

Founding team and executive leadership

Sho Okiyama

Founder CEO

Founding Team

Atsushi Fukuda

取締役CTO

Executive Team

Aillis, Inc. Investors

Notable investors and investment history

Aillis, Inc. investors
InvestorRounds
Keio Innovation InitiativeSeries B
Shionogi & Co.Series B
Nanto BankSeries D
CEJ CapitalSeries C
Monex VenturesSeries D
QB CapitalSeries B
Beyond Next VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2026

    Open roles increased to 8, 2.4x the trailing average.

  • Apr 9, 2026

    Won the 10th Monozukuri Nippon Grand Award.

Aillis, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aillis, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aillis, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range38
Year Founded2017
Last FundingMar 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.